EuBiologics On COVID-19 Vaccine And Fulfilling Public Health Mission
Low-Income Countries Targeted
EuBiologics CEO Yeong Ok Baik sat down with Scrip at CPhI Korea to talk about why he wants to develop vaccines for global public health needs and what plans are in store for its late-stage recombinant protein candidate for COVID-19.
